Ticker change: Syntopix (SYN) changes to Evocutis

RNS Number : 7823Q

Evocutis PLC

25 October 2011

 



Press Release

25 October 2011

Evocutis plc

("the Company")

Ticker change: Syntopix (SYN) changes to Evocutis (EVO)

Evocutis plc, the dermatological experts that deliver innovation through advanced laboratory and clinical evaluations of skincare products for the healthcare and cosmetic markets, today confirms its change of name from Syntopix plc. Evocutis is now trading under the ticker AIM:EVO and its website is live at: www.evocutis.com.

- Ends -

For further information, please contact:

Evocutis plc
Dr Stephen Jones, Chief Executive Officer	[phone]
Tom Bannatyne, Chairman
Zeus Capital ltd
Tom Rowley/Andrew Jones	Tel: [phone]
	www.zeuscapital.co.uk

XCAP Securities plc
Karen Kelly/John Grant	Tel: [phone]
	www.xcapgroup.co.uk

Media enquiries:

Abchurch Communications
Adam Michael/ Jamie Hooper	Tel: [phone]
[e-mail]	www.abchurch-group.com

Notes to editors

About Evocutis plc

With a rich portfolio of new product opportunities Evocutis offers antimicrobial and dermatological expertise to the cosmetic, consumer healthcare and pharmaceutical industries.

Being uniquely able to combine research for laboratory testing, advanced skin models and clinical testing, Evocutis offers a complete service for the development of skin care products and ingredients. Through research and testing we enable our clients to advance the discovery of skin care products that actually work.

Evocutis works with companies at all stages of the product development pipeline offering R&D solutions from ownable technology platforms through to tailored research, and now provides an independent commercial testing facility to the pharmaceutical and healthcare industries. Unique characteristics of its colonised full thickness model of human skin (LabSkin^TM) allow rapid, cost effective screening of, for example, anti-aging, anti-inflammatory and antimicrobial ingredients and products for use on skin.

Offering high quality contract research services, Evocutis specialises in Human Skin Microbiology, tissue culture systems and Human Volunteer and Clinical Dermatology Research.

When it comes to advanced laboratory and clinical evaluations of skincare products for the health and cosmetic markets, the Evocutis focus is simple: intelligent and specialised R&D input. 

For further information, please see www.evocutis.com.

 

END

 

 

MSCUVVWRAKARURA